Background: Interleukin-1b converting enzyme (ICE/caspase-1) is the protease responsible for interleukin-1b (IL-1b) production in monocytes. It was the first member of a new cysteine protease family to be identified. Members of this family have functions in both inflammation and apoptosis. Results: A novel method for identifying protease specificity, employing a positional-scanning substrate library, was used to determine the amino-acid preferences of ICE. Using this method, the complete specificity of a protease can be mapped in the time required to perform one assay. The results indicate that the optimal tetrapeptide recognition sequence for ICE is WEHD, not YVAD, as previously believed, and this led to the synthesis of an unusually potent aldehyde inhibitor, Ac-WEHD-CHO (Ki=56 pM). The structural basis for this potent inhibition was determined by X-ray crystallography.
Introduction
A detailed knowledge of the specificity of a particular protease can provide clues to its biological function(s), and is invaluable for designing appropriate peptidebased substrates and potent, selective inhibitors. Traditionally, most investigations of protease specificity have required the synthesis of large numbers of peptides and/or peptidebased inhibitors, which were analyzed individually for cleavage or inhibition. More recently, several investigators have developed more efficient techniques for determining protease specificity, including substrate phage display, methods for rapid analysis of peptide mixtures, and use of peptide nucleophiles. Positional-scanning synthetic combinatorial libraries (PSSCL) have recently emerged as a powerful method for rapidly identifying high-affinity peptide sequences from a mixture of compounds. Peptide-based PS-SCLs are generally composed of several sub-libraries in which one position is defined with an amino acid, and the remaining positions contain a mixture of amino acids present in approximately equimolar concentrations. Analysis of the library will identify the preferred amino acids for each position. Such libraries have been successfully employed for the identification of potent receptor ligands, enzyme inhibitors , and specific antigens , but have not yet been used to determine protease specificity. Here we describe a novel PS-SCL designed to investigate the specificity of interleukin-1b converting enzyme (ICE/caspase-1, EC 3.4.22.36), the cysteine protease responsible for the production of IL-1b in monocytes. Since its discovery in 1989, this enzyme has been the subject of intense interest as a potential therapeutic target for the treatment of inflammatory diseases. The finding that ICE-deficient mice are resistant to lipopolysaccharide-induced endotoxic shock supports the hypothesis that this enzyme is a key mediator of inflammation. Surprisingly, these mice are defective not only in IL-1b; their ability to make mature IL-1a is also impaired, suggesting that this enzyme has multiple biological functions. ICE is the first identified member of a new cysteine protease family that includes CED-3, the product of a gene required for programmed cell death in the nematode Caenorhabditis elegans. The ICE/CED-3 or caspase family currently includes ten human proteases.
Figure 3:
(e) Electron density in the vicinity of the bound Ac-WEHD-CHO inhibitors. The model is displayed together with electron density from the final map. Residues in the inhibitor are identified with the one-letter code, and residues in the protein by one-letter code and amino-acid sequences number.
Inhibition of ICE by Ac-WEHD-CHO
Upon discovering that the preferred substrate for ICE is Ac-WEHD-AMC, the corresponding tetrapeptide aldehyde was synthesized and tested, in anticipation that it would be a more potent peptide-based inhibitor than those previously described for this enzyme. Peptide aldehydes are effective, competitive, reversible inhibitors of cysteine proteases, forming a thiohemiacetal with the active site cysteine. Inhibition of ICE by Ac-WEHD-CHO is characterized by a relatively slow association rate constant, 2.6´105 M-1s-1, and a dissociation rate constant of 1.5´10-5 s-1, corresponding to an overall dissociation constant (Ki=koff/kon) of 56pM, making it among the most potent reversible inhibitors described for any caspase. This represents an improvement in binding affinity of 14-fold over Ac-YVAD-CHO, the compound previously thought to be the best peptidebased, reversible inhibitor of ICE. Ac-WEHD-CHO is a more potent inhibitor than Ac-YVAD-CHO because there is an increase in the lifetime of the enzyme-inhibitor complex (t1/2 YVAD=0.66 h, t1/2 WEHD=12.8 h) ( Table 2) .
Three-dimensional structure of ICElAc-WEHD-CHO
To understand the structural basis of the improved affinity of Ac-WEHD-CHO, the three-dimensional structure of the ICEl Ac-WEHD-CHO complex was determined by X-ray crystallography, and is compared to that of ICEl Ac-YVAD-CHO in Figure 3 . The overall structures of the two complexes are, in many ways, quite similar. The same three mainchain hydrogen bonds are formed (P1N-Ser339 O, P3N-Arg341 O and P3O-Arg341 N) and comparable interactions are involved in the stabilization of the P1 Asp. In addition, in both structures the chiral center of the hemithioacetal is predominantly in the nontransition state configuration, allowing the hydroxyl group to make a polar interaction with the sidechain of the catalytic His237. In contrast to these similarities, and despite the relatively low resolution (2.7 Å) of these studies, there are clear differences in the protein-inhibitor interactions in the S2, S3 and S4 subsites that appear to account for the increased potency of Ac-WEHD-CHO. First, in both structures the aromatic sidechain contacts the imidazole ring of His342 in S4. In the ICEl Ac-WEHD-CHO crystal, however, the sidechain of Arg383 is rotated away from the conformation seen in the YVAD complex and into a position that would allow a favorable interaction with the partial negative center of the P4 Trp (Fig. 3a,b) . Second, in S3, increased binding energy apparently comes from a salt link between the carboxylate of the P3 Glu and the Nh2 of Arg341 (Fig. 3c,d ). Finally, additional binding energy in S2 appears to arise from a relationship between the inhibitor's histidyl sidechain and Trp340 (Fig. 3d) . The Ne2 atom of the imidazole is appropriately positioned to make a favorable interaction with the partial charges on both the Ch2 and Cz3 atoms of the indole sidechain.
